Immediate Impact
1 by Nobel laureates 2 from Science/Nature 68 standout
Citing Papers
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Michael W. Cannon being referenced
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael W. Cannon | 119 | 182 | 111 | 115 | 22 | 400 | |
| M. Tao | 89 | 125 | 203 | 87 | 18 | 348 | |
| Roberta Lawrence | 85 | 103 | 43 | 104 | 17 | 378 | |
| Chung K. Lee | 94 | 117 | 53 | 54 | 22 | 359 | |
| Gianpaolo Biti | 208 | 194 | 97 | 111 | 15 | 446 | |
| Su-Mi Chung | 84 | 122 | 42 | 109 | 15 | 391 | |
| Ayşe Nur Demiral | 190 | 135 | 22 | 99 | 28 | 384 | |
| Kiran Kothari | 109 | 185 | 105 | 172 | 20 | 440 | |
| D. Khayat | 56 | 165 | 80 | 36 | 29 | 425 | |
| Ding‐Jen Lee | 129 | 181 | 45 | 217 | 22 | 449 | |
| Qin Zhou | 104 | 114 | 26 | 107 | 38 | 413 |
All Works
Loading papers...